Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce Date of FDA Advisory Committee Review of Probuphine for Opioid Addiction

December 9, 2015

Titan Pharmaceuticals Adds ProNeura Implant for Hypothyroidism to Product Development Pipeline

November 16, 2015

Titan Pharmaceuticals Reports Third Quarter 2015 Financial Results

November 16, 2015

Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2015 Financial Results

November 10, 2015

Titan Pharmaceuticals Announces Uplisting to NASDAQ

October 8, 2015

Titan Pharmaceuticals Provides Opinion of Counsel Covering Issuance and Resale of Shares Underlying Public Warrants

October 7, 2015

Titan Pharmaceuticals Announces FDA's Acceptance of Resubmission of New Drug Application for Probuphine

September 28, 2015

Titan Pharmaceuticals Announces Reverse Stock Split

September 28, 2015

Titan Pharmaceuticals to Present at Rodman & Renshaw 17th Annual Global Investment Conference

September 3, 2015

Titan Pharmaceuticals Announces Resubmission of the New Drug Application for Probuphine for the Maintenance Treatment of Opioid Addiction

August 31, 2015

RSS
  • 1
  • 2
  • 3
  • Next »
© 2025 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter